Skip to content
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
PFE$30.02-0.40(-1.31%)Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026[11:18:00 AM ET]BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]
News desk

Live news

Stock news, press releases, and legal notices, with ticker, type, source, and time. Signed-out visitors and Free accounts see the last year, 15 minutes behind. Pro, including the 7-day trial, sees the full archive as each headline is ingested.

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
BBNX Legal BBNX Deadline: BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 ... PR Newswire
MSFT Stock news Microsoft's $50 Billion Gamble: Can Microsoft's Azure Growth Justify Its Exploding AI Budget? 24/7 Wall Street
GOOG Stock news The $500 Billion Question: Can Google Cloud's Massive AI Backlog Outrun Its Mind-Boggling CapEx Boom on Oct. 28? 24/7 Wall Street
BTC Stock news Bitcoin ETFs Just Had Their Biggest Outflow Day Since June. Is the Selling Over? 24/7 Wall Street
TFC Stock news Truist Financial: A Combination Of High-Yielding Preferreds And Common Stock Makes The Most Sense Seeking Alpha
RCL Stock news Debt Anchor vs. Cruise Demand: Can Royal Caribbean's Q3 Print Oct. 27 Match Its Premium Valuation 24/7 Wall Street
MPLX Stock news MPLX Stock Pays a Hefty 7.4% Dividend Yield. Here's How Much $10,000 Generates in Passive Income Each Year. The Motley Fool
Stock news She Will Prepay Her $14,000 Funeral So the Money Is Safe From the Nursing Home. The Funeral Will Cost $9,000, and the Other $5,000 Will Go to the County 247 Wallst
NEM Stock news Newmont Q3 Earnings: Investors Are Walking On Thin Ice Seeking Alpha
CHMG Stock news Chemung Financial: Strong Q3 2026 Results But Watch Out For Balance Sheet Constraints Seeking Alpha
GLW Stock news Can AI Fiber Still Deliver? Corning Faces High-Stakes Q3 Earnings Test Oct. 27 as Valuation Stretches 24/7 Wall Street
HEINY Stock news Weight-Loss Drugs Are Coming for Beer, Heineken Admits Privately 24/7 Wall Street
GTLL Stock news S&P Global's AI Transition Faces Q3 Moment of Truth Oct. 27: Kensho APIs and $11T Refinancing Wall Need to Outrun Sales Bottlenecks 24/7 Wall Street
BA Stock news Is Boeing Cleared for Departure? Latest FAA Win Sets the Stage for Q3 Earnings Showdown on Oct. 27 24/7 Wall Street
IVV Stock news Two-Thirds of S&P 500 Stocks Rose on Thursday, but the Index Still Fell — Exposing the Risk Hiding in Your Portfolio 24/7 Wall Street
BABA Stock news Alibaba vs. Dick's Sporting Goods: Are Sporting Goods Thriving in the U.S. or Asia in 2026? The Motley Fool
ASTS Legal ASTS Deadline in 20 Days: AST SpaceMobile, Inc Class Action Lawsuit: Investors Face November 13, 2026, Deadline - Kessler Topaz Meltzer & Check, LLP Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud... PR Newswire
PFE Press release Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026 Business Wire
AMZN Stock news Can Amazon Take Market Share From Nvidia in the AI Chip Race? The Motley Fool
VRT Stock news Make or Break for VRT on Oct. 28: Proving the ‘AI Factory' Thesis Amid a Brutal Valuation Reset. 24/7 Wall Street
Market Pulse

The same desk, in your inbox.

Market Pulse picks three headlines from the day, names the stock that moved, and shows the call that returns each one.

Monday, Wednesday, and Friday. Unsubscribe from any issue, or from account settings if you have one.

FAQ

Frequently asked questions

Is the live news desk the same feed as the API?
The desk shows the same articles in the browser: ticker, type, source, and published time. Signed-out visitors and Free accounts see the last year, 15 minutes behind. Pro, including the 7-day trial, sees the full archive as soon as a row is ingested. A Free API key returns the last year. Pro keys search the full archive and also include the summary and the original URL.
Why is the live news desk delayed?
Signed-out visitors and Free accounts see this desk 15 minutes behind ingestion, across the last year of headlines. Pro, including the 7-day trial, sees the full archive as soon as headlines are ingested. A Free API key has the same 15-minute delay. The delay is the plan, not an outage, and the status page stays green while the delayed view is on.
How far back does the live news desk go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices, 15 minutes behind ingestion. Pro, including the 7-day trial, sees the full archive as new rows are ingested. Page size is 20. A Free API key returns the last year. Pro keys search the full archive.
How do I see stock news without the 15-minute delay?
Start the 7-day Pro trial and sign in. A card is required. Pro is $15 a month, or $162 a year, and this desk then shows the full archive as headlines are ingested. Signed-out visitors and Free accounts still see the last year of headlines 15 minutes behind. A Free API key stays at 100 requests a day, the same delay, and the last year. One trial per email.
What do the columns on the news desk mean?
Ticker is the symbol attached to the article. Type is stock news, press release, or legal. Headline is the title. Source is the publisher or wire. Published is the article time in Eastern Time. Page size is 20. Use the type buttons when you want wires only, or legal notices kept out of the list.
Can I search the live news desk by ticker?
Yes. The desk has a ticker search, a headline search, a source menu, and buttons for stock news, press releases, and legal notices. Those filters stay on this page. The same filters exist on GET /v1/news if you want the JSON, including the summary and the original URL. Page size on the desk is 20.
How often do new stock headlines appear?
Sources are polled every second, including nights and weekends. Pro, including the 7-day trial, sees a row as soon as it is ingested. Signed-out visitors and Free accounts see that same row 15 minutes later. The desk is a browser view of the API feed, not a second dataset.